rs4029774

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000698776.1(STAT5B):​c.-11+10844T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.366 in 152,136 control chromosomes in the GnomAD database, including 11,612 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.37 ( 11612 hom., cov: 32)

Consequence

STAT5B
ENST00000698776.1 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.427

Publications

19 publications found
Variant links:
Genes affected
STAT5B (HGNC:11367): (signal transducer and activator of transcription 5B) The protein encoded by this gene is a member of the STAT family of transcription factors. In response to cytokines and growth factors, STAT family members are phosphorylated by the receptor associated kinases, and then form homo- or heterodimers that translocate to the cell nucleus where they act as transcription activators. This protein mediates the signal transduction triggered by various cell ligands, such as IL2, IL4, CSF1, and different growth hormones. It has been shown to be involved in diverse biological processes, such as TCR signaling, apoptosis, adult mammary gland development, and sexual dimorphism of liver gene expression. This gene was found to fuse to retinoic acid receptor-alpha (RARA) gene in a small subset of acute promyelocytic leukemias (APLL). The dysregulation of the signaling pathways mediated by this protein may be the cause of the APLL. [provided by RefSeq, Jul 2008]
STAT5B Gene-Disease associations (from GenCC):
  • growth hormone insensitivity syndrome with immune dysregulation
    Inheritance: SD Classification: DEFINITIVE Submitted by: Illumina
  • growth hormone insensitivity syndrome with immune dysregulation 2, autosomal dominant
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • growth hormone insensitivity with immune dysregulation 1, autosomal recessive
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • growth hormone insensitivity syndrome
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.566 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
STAT5BXM_024450897.2 linkc.-11+10844T>C intron_variant Intron 1 of 18 XP_024306665.1
STAT5BXM_047436593.1 linkc.-136+10844T>C intron_variant Intron 1 of 17 XP_047292549.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
STAT5BENST00000698776.1 linkc.-11+10844T>C intron_variant Intron 1 of 18 ENSP00000513923.1 P51692
STAT5BENST00000698777.1 linkc.-11+11517T>C intron_variant Intron 1 of 18 ENSP00000513924.1 P51692
STAT5BENST00000415845.2 linkc.-326T>C upstream_gene_variant 4 ENSP00000398379.2 P51692C9J4I3

Frequencies

GnomAD3 genomes
AF:
0.366
AC:
55579
AN:
152018
Hom.:
11573
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.571
Gnomad AMI
AF:
0.218
Gnomad AMR
AF:
0.214
Gnomad ASJ
AF:
0.337
Gnomad EAS
AF:
0.359
Gnomad SAS
AF:
0.429
Gnomad FIN
AF:
0.237
Gnomad MID
AF:
0.316
Gnomad NFE
AF:
0.294
Gnomad OTH
AF:
0.367
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.366
AC:
55672
AN:
152136
Hom.:
11612
Cov.:
32
AF XY:
0.362
AC XY:
26950
AN XY:
74386
show subpopulations
African (AFR)
AF:
0.572
AC:
23731
AN:
41500
American (AMR)
AF:
0.214
AC:
3276
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.337
AC:
1169
AN:
3468
East Asian (EAS)
AF:
0.361
AC:
1859
AN:
5154
South Asian (SAS)
AF:
0.428
AC:
2066
AN:
4830
European-Finnish (FIN)
AF:
0.237
AC:
2513
AN:
10604
Middle Eastern (MID)
AF:
0.310
AC:
91
AN:
294
European-Non Finnish (NFE)
AF:
0.294
AC:
19993
AN:
67964
Other (OTH)
AF:
0.367
AC:
776
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1737
3473
5210
6946
8683
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
534
1068
1602
2136
2670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.310
Hom.:
11433
Bravo
AF:
0.369
Asia WGS
AF:
0.445
AC:
1544
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
12
DANN
Benign
0.69
PhyloP100
0.43
PromoterAI
0.026
Neutral

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4029774; hg19: chr17-40428961; API